Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study
about
The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.Adult ADHD Medications and Their Cardiovascular ImplicationsA unique pattern of cortical connectivity characterizes patients with attention deficit disorders: a large electroencephalographic coherence study.Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.STEMI Secondary to Coronary Vasospasm: Possible Adverse Event of Methylphenidate in a 21-Year-Old Man with ADHD.The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.The cardiovascular safety of methylphenidateComprehensive review of cardiovascular toxicity of drugs and related agents.Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere.Beneficial effect of statins in patients receiving chronic hemodialysis following percutaneous coronary intervention: A nationwide retrospective cohort study.The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression
P2860
Q33898415-8B8579E4-A23A-42FE-AB18-34F41BAE1005Q34539026-B48672B2-CCF5-4574-9948-6789A97B6479Q36301295-55C2AEA7-7946-4CDB-9D8A-A1EC8A5F8E8DQ37722786-DC6B2268-6958-458F-B9D3-7322409CDF89Q38982262-DDBF6053-0F9F-45D1-ADC1-9E14704EB90BQ39433708-9274B03A-B175-4165-A5FB-D182B01AFCC1Q42748697-7C7C335D-6705-4917-86B2-41988FD10583Q47556269-5A6CC750-92D3-40D2-ACB2-DD3F96EC62BDQ50440637-E71BF3B0-5E80-49AF-A0BE-3A441C30CCCBQ55512228-E6367F6F-0BC2-4015-B58C-E111E3A76E43Q58734154-91206056-5E3F-437C-A41F-80A0025DB5EC
P2860
Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Cardiovascular safety of methy ...... f controlled case series study
@ast
Cardiovascular safety of methy ...... f controlled case series study
@en
Cardiovascular safety of methy ...... f controlled case series study
@nl
type
label
Cardiovascular safety of methy ...... f controlled case series study
@ast
Cardiovascular safety of methy ...... f controlled case series study
@en
Cardiovascular safety of methy ...... f controlled case series study
@nl
prefLabel
Cardiovascular safety of methy ...... f controlled case series study
@ast
Cardiovascular safety of methy ...... f controlled case series study
@en
Cardiovascular safety of methy ...... f controlled case series study
@nl
P2860
P50
P921
P3181
P356
P1433
P1476
Cardiovascular safety of methy ...... f controlled case series study
@en
P2093
Byung-Joo Park
P2860
P3181
P356
10.1136/BMJ.I2550
P407
P577
2016-01-01T00:00:00Z